Lupus, 0961-2033

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population

    R. F. Ingvarsson, A. J. Landgren, A. A. Bengtsson & A. Jönsen, 2019, I : Lupus. 28, 12, s. 1488-1494 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2018
  4. Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment

    K. Chan, A. E. Clarke, R. Ramsey-Goldman, W. Foulkes, B. Tessier Cloutier, M. B. Urowitz, D. Gladman, O. Nived, J. Romero-Diaz, M. Petri, E. Ginzler, P. R. Fortin, S. C. Bae, D. J. Wallace, E. H. Yelin & Sasha Bernatsky, 2018 jan 1, I : Lupus. 27, 1, s. 120-123 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2017
  6. The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients

    M. Y. Choi, A. E. Clarke, Y. St Pierre, J. G. Hanly, M. B. Urowitz, J. Romero-Diaz, C. Gordon, S. C. Bae, S. Bernatsky, D. J. Wallace, J. T. Merrill, D. A. Isenberg, A. Rahman, E. M. Ginzler, M. Petri, I. N. Bruce, M. A. Dooley, P. Fortin, D. D. Gladman, J. Sanchez-Guerrero & 21 andra, K. Steinsson, R. Ramsey-Goldman, M. A. Khamashta, C. Aranow, G. S. Alarcón, S. Manzi, O. Nived, A. A. Zoma, R. F. Van Vollenhoven, M. Ramos-Casals, G. Ruiz-Irastorza, S. S. Lim, K. C. Kalunian, M. Inanc, D. L. Kamen, C. A. Peschken, S. Jacobsen, A. Askanase, J. Buyon, M. Mahler & Marvin J. Fritzler, 2017 sep 1, I : Lupus. 26, 10, s. 1051-1059 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity

    P. Delfani, G. Sturfelt, B. Gullstrand, A. Carlsson, M. Kassandra, C. A K Borrebaeck, A. A. Bengtsson & C. Wingren, 2017 apr 1, I : Lupus. 26, 4, s. 373-387 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.

    Johanna Nagel, Pierre Geborek, Anders Bengtsson, S Jacobsen, Svaerke Joergensen C, Jan-Åke Nilsson, Lillemor Melander Skattum, Andreas Jönsen & Meliha C Kapetanovic, 2017 jan 1, I : Lupus. 1, s. 1-10 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Treatment with belimumab in SLE does not alter antobody response to 13-valent pneumococcal vaccine

    Johanna Nagel, Tore Saxne, Pierre Geborek, Anders Bengtsson, S Jacobsen, Svaerke Joergensen C, Jan-Åke Nilsson, Lillemor Skattum, Andreas Jönsen & Meliha C Kapetanovic, 2017, I : Lupus. 26, 10, s. 1072-1081

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2016
  11. 2015
  12. Anti-C1q antibodies in systemic lupus erythematosus.

    A-M Orbai, Lennart Truedsson, Gunnar Sturfelt, Ola Nived, H Fang, Gs Alarcón, C Gordon, Jt Merrill, Pr Fortin, In Bruce, DA Isenberg, Dj Wallace, R Ramsey-Goldman, S-C Bae, Jg Hanly, J Sanchez-Guerrero, Ae Clarke, Cb Aranow, S Manzi, Mb Urowitz & 33 andra, Dd Gladman, Kc Kalunian, Mi Costner, Vp Werth, A Zoma, S Bernatsky, G Ruiz-Irastorza, Ma Khamashta, S Jacobsen, Jp Buyon, P Maddison, Ma Dooley, Rf Van Vollenhoven, E Ginzler, T Stoll, C Peschken, Jl Jorizzo, Jp Callen, Ss Lim, Bj Fessler, M Inanc, Dl Kamen, A Rahman, K Steinsson, Ag Franks, L Sigler, S Hameed, N Pham, R Brey, Mh Weisman, G McGwin, Ls Magder & M Petri, 2015, I : Lupus. 24, 1, s. 42-49

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis.

    C T Nielsen, O Østergaard, O P Rekvig, Gunnar Sturfelt, S Jacobsen & N H H Heegaard, 2015, I : Lupus. 24, 11, s. 1150-1160

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Hand function and performance of daily activities in systemic lupus erythematosus: a clinical study.

    Pia Malcus Johnsson, Gunnel Sandqvist, J-Å Nilsson, A A Bengtsson, Gunnar Sturfelt & Ola Nived, 2015, I : Lupus. 24, 8, s. 827-834

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2013
  16. Extent and characteristics of self-reported pain in patients with systemic lupus erythematosus

    E. Waldheim, A-C Elkan, Stefan Bergman, J. Frostegard, R. van Vollenhoven & E. Welin Henriksson, 2013, I : Lupus. 22, 2, s. 136-143

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain

    E. Waldheim, A-C Elkan, S. Pettersson, R. van Vollenhoven, Stefan Bergman, J. Frostegard & E. Welin Henriksson, 2013, I : Lupus. 22, 11, s. 1118-1127

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2012
  19. Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study

    Christine Bengtsson, M-L Ohman, Ola Nived & S. Rantapaa Dahlqvist, 2012, I : Lupus. 21, 4, s. 452-459

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus - a possible link to venous thrombosis?

    Christian Lood, Sam Eriksson, Birgitta Gullstrand, Andreas Jönsen, Gunnar Sturfelt, Lennart Truedsson & Anders Bengtsson, 2012, I : Lupus. 21, 13, s. 1423-1432

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. 2011
  22. Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity

    A. Ippolito, D. J. Wallace, D. Gladman, P. R. Fortin, M. Urowitz, V. Werth, M. Costner, C. Gordon, G. S. Alarcon, R. Ramsey-Goldman, P. Maddison, A. Clarke, S. Bernatsky, S. Manzi, S-C Bae, J. T. Merrill, E. Ginzler, J. G. Hanly, Ola Nived, Gunnar Sturfelt & 14 andra, J. Sanchez-Guerrero, I. Bruce, C. Aranow, D. Isenberg, A. Zoma, L. S. Magder, J. Buyon, K. Kalunian, M. A. Dooley, K. Steinsson, R. F. van Vollenhoven, T. Stoll, M. Weisman & M. Petri, 2011, I : Lupus. 20, 3, s. 250-255

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Systemic lupus erythematosus and cardiac risk factors: medical record documentation and patient adherence

    Christine Bengtsson, Anders Bengtsson, K. H. Costenbader, Andreas Jönsen, S. Rantapaa-Dahlqvist, Gunnar Sturfelt & Ola Nived, 2011, I : Lupus. 20, 10, s. 1057-1062

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. 2009
  25. Mitochondrial DNA polymorphisms are associated with susceptibility and phenotype of systemic lupus erythematosus.

    Andreas Jönsen, X Yu, Lennart Truedsson, Ola Nived, Gunnar Sturfelt, S Ibrahim & Aa Bengtsson, 2009, I : Lupus. 18, 4, s. 309-312

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. 2008
  27. Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.

    Ola Nived, Anders Bengtsson, Andreas Jönsen & Gunnar Sturfelt, 2008, I : Lupus. 17, 11, s. 1036-1041

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. 2007
  29. Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire.

    Ola Nived, M Andersson, M Lindgren, P Malcus-Johnsson, A Nihlberg, K Nived, G Reimer-Rasmusson, Gunnar Sturfelt, Christina Ståhl Hallengren & Anders Bengtsson, 2007, I : Lupus. 16, 9, s. 701-706

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort

    M B Urowitz, D Gladman, D Ibanez, P Fortin, J Sanchez-Guerrero, S Bae, A Clarke, S Bernatsky, C Gordon, J Hanly, D Wallace, D Isenberg, E Ginzler, J Merrill, G Alarcon, K Steinsson, M Petri, M A Dooley, I Bruce, S Manzi & 12 andra, M Khamashta, R Ramsey-Goldman, A Zoma, Gunnar Sturfelt, Ola Nived, P Maddison, J Font, R van Vollenhoven, C Aranow, K Kalunian, T Stoll & J Buyon, 2007, I : Lupus. 16, 9, s. 731-735

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 2006
  32. Increased aortic pulse wave velocity in middle aged women with systemic lupus erythematosus

    N Bjarnegard, Christine Bengtsson, Jana Brodszki, Gunnar Sturfelt, Ola Nived & T Lanne, 2006, I : Lupus. 15, 10, s. 644-650

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. 2004
  34. Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus.

    Jana Brodszki, Christine Bengtsson, T Länne, Ola Nived, Gunnar Sturfelt & Karel Marsal, 2004, I : Lupus. 13, 12, s. 917-923

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. ACR classification criteria for systemic lupus erythematosus: complement components

    Ola Nived & Gunnar Sturfelt, 2004, I : Lupus. 13, 11, s. 877-879

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Outcome of incomplete systemic lupus erythematosus after 10 years.

    Christina Ståhl Hallengren, Ola Nived & Gunnar Sturfelt, 2004, I : Lupus. 13, 2, s. 85-88

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. 2003
  38. The ACR nomenclature for CNS lupus revisited.

    Ola Nived, Gunnar Sturfelt, M H Liang & P De Pablo, 2003, I : Lupus. 12, 12, s. 872-876

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.

    Andreas Jönsen, Anders Bengtsson, Ola Nived, Björn Ryberg, Lennart Truedsson, L Rönnblom, G V Alm & Gunnar Sturfelt, 2003, I : Lupus. 12, 11, s. 846-850

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2001
  41. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden

    O Nived, A Bengtsson, A Jönsen, G Sturfelt & H Olsson, 2001, I : Lupus. 10, 7, s. 500-4 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. 2000
  43. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

    Anders Bengtsson, Gunnar Sturfelt, Lennart Truedsson, J Blomberg, G Alm, H Vallin & L Ronnblom, 2000, I : Lupus. 9, 9, s. 664-671

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. 1999
  45. Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus

    Fredrik Tjernström, Gertrud Hellmer, Ola Nived, Lennart Truedsson & Gunnar Sturfelt, 1999, I : Lupus. 8, 2, s. 103-108

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 1996
  47. Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus

    A Bengtsson, Bengt Zöller, Pablo Garcia de Frutos, Björn Dahlbäck & Gunnar Sturfelt, 1996 dec, I : Lupus. 5, 6, s. 598-601 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift